These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7337456)

  • 1. Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
    Breuning SE; Ferguson DG; Cullari S
    Appl Res Ment Retard; 1980; 1(3-4):175-92. PubMed ID: 7337456
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE; Ferguson DG; Cullari S
    Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
    [No Abstract]   [Full Text] [Related]  

  • 3. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized mentally retarded persons.
    Breuning SE; O'Neill MJ; Ferguson DG
    Appl Res Ment Retard; 1980; 1(3-4):253-68. PubMed ID: 7337461
    [No Abstract]   [Full Text] [Related]  

  • 6. Single phenothiazines and tardive dyskinesia.
    Yassa R; Dimitry R
    J Clin Psychiatry; 1983 Jun; 44(6):233-4. PubMed ID: 6853464
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.
    Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1978 Oct; 59(2):105-12. PubMed ID: 103110
    [No Abstract]   [Full Text] [Related]  

  • 8. Mania-induced remission of tardive dyskinesia in manic-depressive illness.
    Weiner WJ; Werner TR
    Ann Neurol; 1982 Aug; 12(2):229-30. PubMed ID: 7125612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
    Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
    Väisänen K; Viukari M; Rimón R; Räisänen P
    Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consent and liability with neuroleptics: the problem of tardive dyskinesia.
    Mills MJ; Norquist GS; Shelton RC; Gelenberg AJ; Van Putten T
    Int J Law Psychiatry; 1986; 8(2):243-52. PubMed ID: 2870031
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of thioridazine on the intellectual performance of mentally retarded drug responders and nonresponders.
    Breuning SE; Ferguson DG; Davidson NA; Poling AD
    Arch Gen Psychiatry; 1983 Mar; 40(3):309-13. PubMed ID: 6338856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia?
    Faheem AD; Brightwell DR; Burton GC; Struss A
    Am J Psychiatry; 1982 Apr; 139(4):517-8. PubMed ID: 6121492
    [No Abstract]   [Full Text] [Related]  

  • 18. Tardive Tourette syndrome.
    DeVeaugh-Geiss J
    Neurology; 1980 May; 30(5):562-3. PubMed ID: 6102749
    [No Abstract]   [Full Text] [Related]  

  • 19. Metoclopramide, an increasingly recognized cause of tardive dyskinesia.
    Kenney C; Hunter C; Davidson A; Jankovic J
    J Clin Pharmacol; 2008 Mar; 48(3):379-84. PubMed ID: 18223146
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical evaluation of mesoridazine in mentally retarded patients.
    Zaleski W
    Can Psychiatr Assoc J; 1970 Jun; 15(3):319-22. PubMed ID: 4913609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.